Difference between revisions of "CNS5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(7 intermediate revisions by the same user not shown)
Line 5: Line 5:
 
If empty (no name is present), please volunteer to create content for that disease!
 
If empty (no name is present), please volunteer to create content for that disease!
  
−
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
+
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
−
 
 
−
<br />
 
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
 
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
Line 19: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
−
|Astrocystoma, IDH-Mutant
+
|CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 
|Disease
 
|Disease
 
|Meenakshi Mehrotra
 
|Meenakshi Mehrotra
Line 30: Line 48:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
+
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 +
|Disease
 +
|Riley Lochner (trainee), Shashi Shetty (mentor)
 
|6/7/2022
 
|6/7/2022
 
|
 
|
Line 39: Line 59:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Glioblastoma, IDH-Wildtype||Disease||Meenakshi Mehrotra
+
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 +
|Disease
 +
|Meenakshi Mehrotra
 
|
 
|
 
|
 
|
Line 46: Line 68:
 
|LS
 
|LS
 
|
 
|
−
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
+
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
 
|-
 
|-
−
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
+
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 +
|Disease
 +
|Scott Smith
 
|6/27/2023
 
|6/27/2023
 
|
 
|
Line 57: Line 81:
 
|2021 template added (page created 6/27/23)
 
|2021 template added (page created 6/27/23)
 
|-
 
|-
−
|Angiocentric Glioma||Disease||
+
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 66: Line 92:
 
|
 
|
 
|-
 
|-
−
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
+
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 75: Line 103:
 
|
 
|
 
|-
 
|-
−
|Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease||
+
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 84: Line 114:
 
|
 
|
 
|-
 
|-
−
|Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
+
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 +
|Disease
 +
|Laveniya Satgunaseelan (Linda Cooley - previous version)
 
|
 
|
 
|
 
|
Line 93: Line 125:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
+
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 +
|Disease
 +
|Xiaolin (Lynn) Hu
 
|2/21/2022
 
|2/21/2022
 
|
 
|
Line 102: Line 136:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
+
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 +
|Disease
 +
|Madina Sukhanova
 
|10/28/2022
 
|10/28/2022
 
|
 
|
Line 111: Line 147:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Infant-Type Hemispheric Glioma||Disease||
+
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 +
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 118: Line 157:
 
|
 
|
 
|
 
|
−
|2021 template added
 
 
|-
 
|-
−
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
+
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
 +
|Disease
 +
|Jeremy Pulvers
 
|9/13/2022<br />
 
|9/13/2022<br />
 
|
 
|
Line 129: Line 169:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|High-Grade Astrocytoma with Piloid Features||Disease||
+
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 138: Line 180:
 
|
 
|
 
|-
 
|-
−
|Pleomorphic Xanthoastrocytoma||Disease||
+
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 147: Line 191:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Subependymal Giant Cell Astrocytoma||Disease||
+
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 156: Line 202:
 
|
 
|
 
|-
 
|-
−
|Chordoid Glioma||Disease||
+
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 165: Line 213:
 
|
 
|
 
|-
 
|-
−
|Astroblastoma, MN1-Altered||Disease||
+
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 174: Line 224:
 
|
 
|
 
|-
 
|-
−
|Ganglioglioma||Disease||Leila Moayed-Aloei
+
|[[CNS5:Ganglioglioma|Ganglioglioma]]
 +
|Disease
 +
|Leila Moayed-Aloei
 
|6/30/2022
 
|6/30/2022
 
|
 
|
Line 183: Line 235:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Gangliocytoma||Disease||
+
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 192: Line 257:
 
|
 
|
 
|-
 
|-
−
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
+
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 201: Line 268:
 
|
 
|
 
|-
 
|-
−
|Dysembryoplastic Neuroepithelial Tumour||Disease||
+
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 210: Line 279:
 
|
 
|
 
|-
 
|-
−
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
+
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 219: Line 290:
 
|
 
|
 
|-
 
|-
−
|Papillary Glioneuronal Tumour||Disease||
+
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 228: Line 301:
 
|
 
|
 
|-
 
|-
−
|Rosette-Forming Glioneuronal Tumour||Disease||
+
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 237: Line 312:
 
|
 
|
 
|-
 
|-
−
|Myxoid Glioneuronal Tumour||Disease||
+
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 246: Line 323:
 
|
 
|
 
|-
 
|-
−
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
+
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 255: Line 334:
 
|
 
|
 
|-
 
|-
−
|Multinodular and Vacuolating Neuronal Tumour||Disease||
+
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 264: Line 345:
 
|
 
|
 
|-
 
|-
−
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
+
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 273: Line 367:
 
|
 
|
 
|-
 
|-
−
|Central Neurocytoma||Disease||
+
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 282: Line 378:
 
|
 
|
 
|-
 
|-
−
|Extraventricular Neurocytoma||Disease||
+
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 291: Line 389:
 
|
 
|
 
|-
 
|-
−
|Cerebellar Liponeurocytoma||Disease||
+
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 300: Line 400:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma||Disease||
+
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 309: Line 411:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
+
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 318: Line 422:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
+
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 327: Line 433:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Ependymoma||Disease||
+
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 336: Line 444:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
+
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 345: Line 455:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
+
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 354: Line 466:
 
|
 
|
 
|-
 
|-
−
|Spinal Ependymoma||Disease||
+
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 363: Line 477:
 
|
 
|
 
|-
 
|-
−
|Spinal Ependymoma, MYCN-Amplified||Disease||
+
|[[CNS5:Subependymoma|Subependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 372: Line 488:
 
|
 
|
 
|-
 
|-
−
|Myxopapillary Ependymoma||Disease||
+
|CHAPTER 3 (CHOROID PLEXUS TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Subependymoma||Disease||
+
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 390: Line 519:
 
|
 
|
 
|-
 
|-
−
|Choroid Plexus Papilloma||Disease||
+
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 399: Line 530:
 
|
 
|
 
|-
 
|-
−
|Atypical Choroid Plexus Papilloma||Disease||
+
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 408: Line 541:
 
|
 
|
 
|-
 
|-
−
|Choroid Plexus Carcinoma||Disease||
+
|CHAPTER 4 (EMBRYONAL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
+
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 +
|Disease
 +
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
 
|9/20/21
 
|9/20/21
 
|
 
|
Line 426: Line 572:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
+
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 435: Line 616:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
+
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 444: Line 627:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
+
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 453: Line 638:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, Histologically Defined||Disease||
+
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 462: Line 682:
 
|
 
|
 
|-
 
|-
−
|Atypical Teratoid/Rhabdoid Tumour||Disease||
+
|CHAPTER 5 (PINEAL TUMOURS)
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Cribriform Neuroepithelial Tumour||Disease||
+
|[[CNS5:Pineocytoma|Pineocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 480: Line 713:
 
|
 
|
 
|-
 
|-
−
|Embryonal Tumour with Multilayered Rosettes||Disease||
+
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 489: Line 724:
 
|
 
|
 
|-
 
|-
−
|CNS Neuroblastoma, FOXR2-Activated||Disease||
+
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 498: Line 735:
 
|
 
|
 
|-
 
|-
−
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
+
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 507: Line 746:
 
|
 
|
 
|-
 
|-
−
|CNS Embryonal Tumour NEC/NOS||Disease||
+
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 516: Line 757:
 
|
 
|
 
|-
 
|-
−
|Pineocytoma||Disease||
+
|CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
+
|[[CNS5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 534: Line 788:
 
|
 
|
 
|-
 
|-
−
|Pineoblastoma||Disease||
+
|[[CNS5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 543: Line 799:
 
|
 
|
 
|-
 
|-
−
|Papillary Tumour of the Pineal Region||Disease||
+
|[[CNS5:Perineurioma|Perineurioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 552: Line 810:
 
|
 
|
 
|-
 
|-
−
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
+
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 561: Line 821:
 
|
 
|
 
|-
 
|-
−
|Schwannoma||Disease||
+
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 570: Line 832:
 
|
 
|
 
|-
 
|-
−
|Neurofibroma||Disease||
+
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 579: Line 843:
 
|
 
|
 
|-
 
|-
−
|Perineurioma||Disease||
+
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 588: Line 854:
 
|
 
|
 
|-
 
|-
−
|Hybrid Nerve Sheath Tumours||Disease||
+
|CHAPTER 7 (MENINGIOMA)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Malignant Melanotic Nerve Sheath Tumour||Disease||
+
|[[CNS5:Meningioma|Meningioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 606: Line 885:
 
|
 
|
 
|-
 
|-
−
|Malignant Peripheral Nerve Sheath Tumour||Disease||
+
|CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
+
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 624: Line 916:
 
|
 
|
 
|-
 
|-
−
|Meningioma||Disease||
+
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 633: Line 927:
 
|
 
|
 
|-
 
|-
−
|Solitary Fibrous Tumour||Disease||
+
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 642: Line 938:
 
|
 
|
 
|-
 
|-
−
|Haemangiomas and Vascular Malformations||Disease||
+
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 651: Line 949:
 
|
 
|
 
|-
 
|-
−
|Haemangioblastoma||Disease||
+
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 660: Line 960:
 
|
 
|
 
|-
 
|-
−
|Rhabdomyosarcoma||Disease||
+
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 669: Line 971:
 
|
 
|
 
|-
 
|-
−
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
+
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 678: Line 982:
 
|
 
|
 
|-
 
|-
−
|CIC-Rearranged Sarcoma||Disease||
+
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 687: Line 993:
 
|
 
|
 
|-
 
|-
−
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
+
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 696: Line 1,004:
 
|
 
|
 
|-
 
|-
−
|Ewing Sarcoma||Disease||
+
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 705: Line 1,015:
 
|
 
|
 
|-
 
|-
−
|Mesenchymal Chondrosarcoma||Disease||
+
|[[CNS5:Chordoma|Chordoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 714: Line 1,026:
 
|
 
|
 
|-
 
|-
−
|Chondrosarcoma||Disease||
+
|CHAPTER 9 (MELANOCYTIC TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Chordoma||Disease||
+
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 732: Line 1,057:
 
|
 
|
 
|-
 
|-
−
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
+
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 741: Line 1,068:
 
|
 
|
 
|-
 
|-
−
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
+
|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
+
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 759: Line 1,099:
 
|
 
|
 
|-
 
|-
−
|Immunodeficiency-Associated CNS Lymphomas||Disease||
+
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 768: Line 1,110:
 
|
 
|
 
|-
 
|-
−
|Lymphomatoid Granulomatosis||Disease||
+
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 777: Line 1,121:
 
|
 
|
 
|-
 
|-
−
|Intravascular Large B-cell Lymphoma||Disease||
+
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 786: Line 1,132:
 
|
 
|
 
|-
 
|-
−
|MALT Lymphoma of the Dura||Disease||
+
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 795: Line 1,143:
 
|
 
|
 
|-
 
|-
−
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
+
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 804: Line 1,154:
 
|
 
|
 
|-
 
|-
−
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
+
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 +
|Disease
 +
|Jennie Thurston
 
|7/2/2023
 
|7/2/2023
 
|
 
|
Line 811: Line 1,163:
 
|MS
 
|MS
 
|
 
|
−
|2021 template added
+
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
 +
|-
 +
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
|T-cell and NK/T-cell Lymphomas||Disease||
+
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 822: Line 1,220:
 
|
 
|
 
|-
 
|-
−
|Erdheim-Chester Disease||Disease||
+
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 831: Line 1,231:
 
|
 
|
 
|-
 
|-
−
|Rosai-Dorfman Disease||Disease||
+
|CHAPTER 11 (GERM CELL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Juvenile Xanthogranuloma||Disease||
+
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 849: Line 1,262:
 
|
 
|
 
|-
 
|-
−
|Langerhans Cell Histiocytosis||Disease||
+
|CHAPTER 12 (TUMOURS OF THE SELLAR REGION
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Histiocytic Sarcoma||Disease||
+
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 867: Line 1,293:
 
|
 
|
 
|-
 
|-
−
|Germ Cell Tumours of the CNS||Disease||
+
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 876: Line 1,304:
 
|
 
|
 
|-
 
|-
−
|Adamantinomatous Craniopharyngioma||Disease||
+
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 885: Line 1,315:
 
|
 
|
 
|-
 
|-
−
|Papillary Craniopharyngioma||Disease||
+
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 894: Line 1,326:
 
|
 
|
 
|-
 
|-
−
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
+
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 903: Line 1,337:
 
|
 
|
 
|-
 
|-
−
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
+
|CHAPTER 13 (METASTASES TO THE CNS)
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Pituitary Blastoma||Disease||
+
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 921: Line 1,368:
 
|
 
|
 
|-
 
|-
−
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
+
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 930: Line 1,379:
 
|
 
|
 
|-
 
|-
−
|Metastases to the Meninges||Disease||
+
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
+
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|Ngoni Faya (trainee) + Madina Sukhanova
 
|
 
|
 
|
 
|
Line 948: Line 1,410:
 
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|-
 
|-
−
|Neurofibromatosis Type 2||Disease||
+
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 957: Line 1,421:
 
|
 
|
 
|-
 
|-
−
|Schwannomatosis||Disease||
+
|[[CNS5:Schwannomatosis|Schwannomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 966: Line 1,432:
 
|
 
|
 
|-
 
|-
−
|Von Hippel-Lindau Syndrome||Disease||
+
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 975: Line 1,443:
 
|
 
|
 
|-
 
|-
−
|Tuberous Sclerosis||Disease||
+
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 984: Line 1,454:
 
|
 
|
 
|-
 
|-
−
|Li-Fraumeni Syndrome||Disease||
+
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 993: Line 1,465:
 
|
 
|
 
|-
 
|-
−
|Cowden Syndrome||Disease||
+
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,002: Line 1,476:
 
|
 
|
 
|-
 
|-
−
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
+
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 +
|Disease
 +
|Jennie Thurston
 
|7/2/2023
 
|7/2/2023
 
|
 
|
Line 1,011: Line 1,487:
 
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|-
 
|-
−
|Familial Adenomatous Polyposis 1||Disease||Jennifer Laffin
+
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 +
|Disease
 +
|Jennifer Laffin
 
|8/22/2023
 
|8/22/2023
 
|
 
|
Line 1,020: Line 1,498:
 
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|-
 
|-
−
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
+
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,029: Line 1,509:
 
|
 
|
 
|-
 
|-
−
|Rhabdoid Tumour Predisposition Syndrome||Disease||
+
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,038: Line 1,520:
 
|
 
|
 
|-
 
|-
−
|Carney Complex||Disease||
+
|[[CNS5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,047: Line 1,531:
 
|
 
|
 
|-
 
|-
−
|DICER1 Syndrome||Disease||Jennie Thurston
+
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 +
|Disease
 +
|Jennie Thurston
 
|7/2/2023
 
|7/2/2023
 
|
 
|
Line 1,056: Line 1,542:
 
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
|-
 
|-
−
|Familial Paraganglioma Syndromes||Disease||
+
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,065: Line 1,553:
 
|
 
|
 
|-
 
|-
−
|Melanoma-Astrocytoma Syndrome||Disease||
+
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,074: Line 1,564:
 
|
 
|
 
|-
 
|-
−
|Familial Retinoblastoma||Disease||
+
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,083: Line 1,575:
 
|
 
|
 
|-
 
|-
−
|BAP1 Tumour Predisposition Syndrome||Disease||
+
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,092: Line 1,586:
 
|
 
|
 
|-
 
|-
−
|Fanconi Anaemia||Disease||
+
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,101: Line 1,597:
 
|
 
|
 
|-
 
|-
−
|ELP1-Medulloblastoma Syndrome||Disease||
+
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,110: Line 1,608:
 
|
 
|
 
|-
 
|-
−
|}<br />
+
|}

Latest revision as of 14:00, 25 February 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
Astrocytoma, IDH-mutant Disease Meenakshi Mehrotra 6/25/2023 PENDING Laveniya Satgunaseelan (LS) 2021 template added
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease Riley Lochner (trainee), Shashi Shetty (mentor) 6/7/2022 COMPLETE LS 2021 template added
Glioblastoma, IDH-wildtype Disease Meenakshi Mehrotra PENDING LS Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
Diffuse astrocytoma, MYB- or MYBL1-altered Disease Scott Smith 6/27/2023 PENDING LS 2021 template added (page created 6/27/23)
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease
Diffuse midline glioma, H3 K27-altered Disease Laveniya Satgunaseelan (Linda Cooley - previous version) PENDING LS 2021 template added
Diffuse hemispheric glioma, H3 G34-mutant Disease Xiaolin (Lynn) Hu 2/21/2022 COMPLETE LS 2021 template added
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease Madina Sukhanova 10/28/2022 COMPLETE LS 2021 template added
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease Jeremy Pulvers 9/13/2022
 PENDING LS 2021 template added
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease LS 2021 template added
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease Leila Moayed-Aloei 6/30/2022 COMPLETE LS 2021 template added
Gangliocytoma Disease
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Myxopapillary ependymoma Disease
Subependymoma Disease
CHAPTER 3 (CHOROID PLEXUS TUMOURS)
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease
CHAPTER 4 (EMBRYONAL TUMOURS)
Medulloblastoma, WNT-activated Disease Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City 9/20/21 COMPLETE Holli Drendel (interim)/Laveniya Satgunaseelan (LS) 9/22/2022 2021 template added
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease
CHAPTER 5 (PINEAL TUMOURS)
Pineocytoma Disease
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease
CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumours Disease
Malignant melanotic nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease
CHAPTER 7 (MENINGIOMA)
Meningioma Disease
CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
Solitary fibrous tumour Disease
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
CIC-rearranged sarcoma Disease
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease
Mesenchymal chondrosarcoma Disease
Chondrosarcoma Disease
Chordoma Disease
CHAPTER 9 (MELANOCYTIC TUMOURS)
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease
CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
Primary diffuse large B-cell lymphoma of the CNS Disease
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease
Intravascular large B-cell lymphoma Disease
MALT lymphoma of the dura Disease
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease Jennie Thurston 7/2/2023 PENDING MS 2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)" and "ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)"?
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Juvenile xanthogranuloma Disease
Langerhans cell histiocytosis Disease
Histiocytic sarcoma Disease
CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours of the CNS Disease
CHAPTER 12 (TUMOURS OF THE SELLAR REGION
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
CHAPTER 13 (METASTASES TO THE CNS)
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease
CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
Neurofibromatosis type 1 Disease Ngoni Faya (trainee) + Madina Sukhanova NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
Neurofibromatosis type 2 Disease
Schwannomatosis Disease
Von Hippel-Lindau syndrome Disease
Tuberous sclerosis Disease
Li-Fraumeni syndrome Disease
Cowden syndrome Disease
Constitutional mismatch repair deficiency syndrome Disease Jennie Thurston 7/2/2023 PENDING LS NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
Familial adenomatous polyposis 1 Disease Jennifer Laffin 8/22/2023 PENDING LS/MS NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
Naevoid basal cell carcinoma syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Carney complex Disease
DICER1 syndrome Disease Jennie Thurston 7/2/2023 PENDING LS NOT YET CREATED - See page "DICER1-Related Tumour Predisposition Syndrome (DICER1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
Familial paraganglioma syndromes Disease
Melanoma-astrocytoma syndrome Disease
Familial retinoblastoma Disease
BAP1 tumour predisposition syndrome Disease
Fanconi anaemia Disease
ELP1-medulloblastoma syndrome Disease
Retrieved from "https://content.ccga.io/index.php?title=CNS5:Volunteer_Assignments_and_Opportunities&oldid=14251"